Clinical Trials Browser

Phase 1/2 × Neoplasms × tomivosertib × Clear all

NCT02605083 2020-11-02

A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors

Phase 1/2 Terminated

DermatologicHead & Neck

Melanoma, Neoplasms, Thyroid Diseases